Deficient expression of the RNase III DICER1, which leads to the accumulation of cytotoxic Alu RNA, has been implicated in degeneration of the retinal pigmented epithelium (RPE) in geographic atrophy (GA), a late stage of age-related macular degeneration that causes blindness in millions of people worldwide. Here we show increased extracellular-signal-regulated kinase (ERK) 1/2 phosphorylation in the RPE of human eyes with GA and that RPE degeneration in mouse eyes and in human cell culture induced by DICER1 depletion or Alu RNA exposure is mediated via ERK1/2 signaling. Alu RNA overexpression or DICER1 knockdown increases ERK1/2 phosphorylation in the RPE in mice and in human cell culture. Alu RNA-induced RPE degeneration in mice is rescued by intravitreous administration of PD98059, an inhibitor of the ERK1/2-activating kinase MEK1, but not by inhibitors of other MAP kinases such as p38 or JNK. These findings reveal a previously unrecognized function of ERK1/2 in the pathogenesis of GA and provide a mechanistic basis for evaluation of ERK1/2 inhibition in treatment of this disease.
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cell death | mobile elements | retinal degeneration T he Alu family of short interspersed elements (SINEs), the most abundant interspersed repeats in the human genome (1), has propagated to over 1 million copies via retrotransposition (2) (3) (4) . These mobile elements have been considered selfish "junk DNA" entities in the host genome. However, it is now recognized that the RNAs transcribed from Alu and the related B1/B2 SINEs in rodents have complex regulatory functions such as transcriptional repression (5-7) and modulation of alternative splicing (8) .
Although Alu polymorphisms confer significant genetic diversity to the human population (2), sporadic Alu insertions and Alu-mediated unequal recombination also cause a host of human genetic diseases (9) . Indeed, Alu-mediated chromosomal disruption is involved in neurofibromatosis (10), hypercholesterolemia (11) , and several cancers (12-14) via de novo insertion or recombination.
Recently, we identified Alu RNA as an enzymatic substrate for the RNase DICER1 (15) and showed that Alu RNA abundance is increased following DICER1 deficit in the retinal pigment epithelium (RPE) of human eyes with geographic atrophy (GA), the advanced non-neovascular form of age-related macular degeneration (AMD) that is characterized by RPE cell degeneration. Alu RNA accumulation following DICER1 deficiency induces human RPE cell death and RPE degeneration in mice via activation of caspase-1 and -3 and, remarkably, is also independent of miRNA and toll-like receptor pathways (15, 16) . Still, the signaling mediators of Alu RNA cytotoxicity remain to be fully defined. We tested the hypothesis that mitogen-activated protein kinases (MAPK) might be involved in Alu-induced cell death, as MAPK protein phosphorylation is a prerequisite for many signal transduction pathways and, in particular, cell death (17). Here we identify activation of extracellular-signal-regulated kinase (ERK) 1/2-the "classical MAPKs"-as key mediators of DICER1 dysregulation or Alu RNA accumulation-induced RPE cell death in GA.
Results ERK1/2 Activation in Human GA RPE. The clinical and pathological hallmark of GA in human eyes is RPE degeneration (18) . In the atrophic macular region in human GA eyes (Fig. 1A) , there is marked disruption of the tight-junction associated protein zonula occludens-1 (ZO-1) and dysmorphology of the RPE cell monolayer (Fig. 1B) . In this diseased macular RPE, we observed increased levels of ERK1/2 MAPK phosphorylation compared with non-AMD eyes (Fig. 1C) . In contrast, there was no difference in the phosphorylation of p38 MAPK and JNK1/2 (Fig. 1C ) or in the expression of total ERK1/2 in diseased vs. nondiseased RPE. DICER1 mRNA abundance and protein levels were significantly reduced in RPE of these GA eyes compared with control RPE (Fig. 1 D and E) , confirming our earlier observations (15) . Similarly, as we reported earlier (15) , there was a dramatic increase in the abundance of Alu RNA in GA RPE compared with normal RPE (Fig. 1F ).
DICER1 Knockdown Activates ERK1/2. We hypothesized that ERK1/2 activation in the RPE of GA tissue was a consequence of reduced DICER1 levels. Dicer1 was knocked out in mouse RPE by subretinal administration of an adeno-associated viral vector (AAV) coding for Cre recombinase under the control of the RPE-specific BEST1 promoter (AAV1-BEST1-Cre) (19) in Dicer1 f/f mice. As in our prior studies, this Dicer1 deficit induced RPE degeneration as visualized by fundus imaging or by immunofluorescent analysis of the spatial distribution of ZO-1 ( Fig. 2A) . In contrast, contralateral eyes treated with control AAV1-BEST1-GFP or wild-type mouse eyes injected with subretinal AAV1-BEST1-Cre did not exhibit RPE degeneration. We confirmed that Dicer1 was knocked out in the RPE in vivo (Fig. S1A ) and that this resulted in increased abundance of B1 and B2 RNAs (Fig. S1B) , which are Alu-like SINE elements in mice. Dicer1 knockout also specifically induced ERK1/2 phosphorylation in mouse RPE in vivo; p38 MAPK or JNK1/2 phosphorylation levels were unchanged (Fig. 2B ). Consonant with this observation, we found that inhibition of Dicer1 by Ad-Cre administration in Dicer1 f/f mouse RPE cells induced a marked increase in ERK1/2 phosphorylation ( Fig. 2C ) with no effect on p38 or JNK1/2 activation. Similarly, antisense oligonucleotide-mediated knockdown of DICER1 in primary human RPE cells increased phosphorylation of ERK1/2, but not of p38 or JNK1/2, as assessed by Western blotting and immunofluorescence analysis ( Fig. 2 D and E) . Collectively, these data demonstrate that loss of DICER1 promotes activation of ERK1/2.
Alu/B1/B2 RNA Induces ERK1/2 Activation. Having previously identified Alu RNA as an enzymatic substrate of DICER1 cleavage and as abundant in GA RPE (15), we next tested whether Alu/B1/ B2 RNA similarly triggers ERK1/2 activation. Subretinal injection of plasmids coding for Alu RNA (pAlu) or for B1 or B2 RNAs induced RPE degeneration ( Fig. 3 A and B ) and ERK1/2 phosphorylation ( Fig. 3 C and D) in wild-type mice. Alu promoted specific phosphorylation of the ERK1/2 MAPK family, but not of two other MAPK families, because pAlu did not increase p38 MAPK or JNK1/2 phosphorylation in wild-type mouse RPE in vivo (Fig. 3C ) or in cell culture (Fig. 3E) . Consistent with this finding, both pAlu and in vitro-transcribed Alu RNA induced robust ERK1/2 phosphorylation in human RPE cells without affecting p38 or JNK1/2 activity (Fig. 3 F and G) . Plasmids encoding B1 and B2 expression increased ERK1/2 activation in wild-type mouse RPE in vivo and in cell culture, indicating conservation of this effect in the related mouse repetitive element transcripts ( Fig. 3 D and H) . Together, these data confirm that Alu RNA specifically promotes ERK1/2 activation. ERK1/2 Mediates DICER1 Deficit-Induced RPE Degeneration. We previously established that loss of DICER1 promotes RPE cell death (15, 16) . Having determined that DICER1 deficit also induces ERK1/2 signaling in RPE, we tested whether ERK1/2 activation was necessary for RPE degeneration. Indeed, RPE degeneration in Dicer1 f/f mice, induced by AAV-BEST1-Cre, was rescued by intravitreous administration of the MAPKK (MEK1) inhibitor PD98059, which blocks ERK phosphorylation, but not by inhibitors of p38 MAPK (SB202190) or JNK (SP600125) (Fig.  4A) . Similarly, PD98059 also protected against human and wildtype mouse RPE cytotoxicity induced by DICER1 depletion (Fig. 4 B and C) . In contrast, the p38 MAPK and JNK inhibitors did not rescue human or mouse RPE cell viability. We confirmed the mechanism of action of PD98059 by finding that it blocked ERK1/2 activation induced by DICER1 knockdown in human or wild-type mouse RPE cells (Fig. 4 D-F) . Furthermore, subretinal delivery of a plasmid coding for full-length MAPKKK (MEK1), which activates ERK1/2 (20), induced RPE degeneration in wildtype mice (Fig. 4G) , supporting the concept that ERK1/2 activation is sufficient to induce RPE degeneration. Collectively, these data identify ERK1/2 as an essential component of DICER1 deficit-induced RPE degeneration.
ERK1/2 Mediate Alu/B1/B2-Induced RPE Degeneration. We evaluated whether Alu, B1, and B2 RNAs require ERK1/2 activation to promote RPE degeneration. The MEK inhibitor PD98059 prevented RPE degeneration induced by Alu RNA (Fig. 5A ) or B1/B2 RNA in wild-type mice (Fig. 5B) . In contrast, p38 or JNK1/2 inhibitors did not confer protection against Alu-induced RPE degeneration even when used at concentrations supramolar to the ERK inhibitor ( Fig. 5A and Fig. S2A ). Similarly, treatment of primary human or wild-type mouse RPE cells with PD98059, but not with p38 or JNK1/2 inhibitors, prevented pAlu-induced cell death (Fig. 5 C and D) . We confirmed that PD98059, but not SB202190 or SP600125, reduced pAlu-induced ERK1/2 phosphorylation in both human and wild-type mouse RPE cells (Fig. S2 B-E), confirming its mode of action. Together, these data reveal ERK1/2 activation as necessary for Alu RNA-mediated RPE degeneration.
Alu Accumulation Is Responsible for DICER1 Deficit-Induced ERK1/2
Activation. Because DICER1 reduction not only can lead to the accumulation of Alu RNA but also can induce miRNA expression deficits, we sought to determine whether Alu RNA accumulation was responsible for DICER1 deficit-induced ERK1/2 activation. Indeed, both ERK1/2 phosphorylation and cell death induced by DICER1 depletion in human RPE cells were inhibited by antisense oligonucleotides targeting Alu RNA sequences, but not by scrambled antisense control (Fig. 6 A-C) . These data indicate that DICER1 dysregulation promotes ERK1/2 activation via Alu RNA accumulation.
Discussion
In this study, we have extended our earlier observation that in human eyes with GA there is a deficiency of DICER1 and accumulation of Alu RNA in the RPE, and we also identified ERK1/2 activation as a signaling mediator of Alu RNA/DICER1 deficit-induced RPE degeneration. We found that there is increased activation of these MAP kinases in the RPE of human eyes with GA and that DICER1 loss or Alu RNA excess activates ERK1/2 in vivo. The critical nature of ERK1/2 activation in mediating RPE cytotoxicity in the context of DICER1/Alu RNA imbalance was demonstrated by rescuing RPE degeneration both in RPE cell culture and in mice via inhibition of ERK1/2. We previously reported that RPE degeneration in DICER1-deficient or Alu RNA excess states is mediated by IL-18 derived from NLRP3 inflammasome activation (16) . However, the ensuing signaling pathways that trigger RPE cell death are undefined. Our finding that RPE degeneration is mediated through ERK1/2 activation elucidates the cell death mechanisms downstream of IL-18 and is compatible with earlier observations that IL-18 can activate ERK1/2 (21) .
Akin to the RPE, conditional ablation of Dicer1 in the forebrain has been reported to induce ERK1 activation (22); however, the pathway linking these events remains to be resolved. Oxidative stress, which is postulated to be a key driver of AMD pathogenesis (23) , is an attractive candidate. Previously, we have shown that hydrogen peroxide-induced oxidative stress down-regulates DICER1 (15) and that DICER1/Alu RNA dysregulation induces mitochondrial ROS production in RPE cells (16) . It is also known that chemically induced oxidative stress can trigger ERK1/2 activation in RPE cells (24) . In addition, ERK1/2 activation can feed-forward to exacerbate oxidative stress (25) . As might be expected from the complexity of stress-related signaling pathways, ERK1/2 activation can promote both cell survival and apoptosis in a context-dependent manner (25, 26) . One reason for these conflicting data might be the dichotomous response of ERK1/2 activation promoting cell survival in transient injury and cell death in chronic states (27) . Consistent with this temporal dichotomy, ERK1/2 activation promotes cell death in a variety of chronic neurodegenerative states (27) . Thus, our finding that ERK1/2 activation triggers RPE cell death in GA is compatible with the chronic nature of AMD progression.
Collectively, our findings-that there is increased activation of ERK1/2 in the RPE of human eyes with GA and that ERK1/2 inhibition blocks RPE degeneration in an in vivo model that recapitulates the DICER1/Alu RNA imbalance existing in the human disease state-provide a molecular rationale for exploring ERK1/2 inhibition strategies in atrophic AMD. In addition, ERK1/2 pathways also regulate angiogenesis and are involved in experimental models of retinal and choroidal neovascularization (28, 29) . Thus, ERK1/2 activation also is a potentially attractive dual target for both atrophic and neovascular AMD. However, given the contextual roles of ERK1/2 activation in cell survival and death, pharmacological modulation of this signaling pathway is likely to demand careful optimization.
Materials and Methods
Descriptions of the following are available in SI Materials and Methods: Plasmids, mouse and human primary RPE cell isolation, culture and treatment, viral vectors, real-time PCR, antibodies, reagents, RNA isolation, immunolabeling, and protein quantification.
Animals. C57BL/6J and Dicer1 f/f mice were purchased from The Jackson
Laboratory. Ablation of Dicer1 in these mice was accomplished using adenoassociated virus vector coding for Cre recombinase under control of an RPEspecific promoter.
Subretinal Injection. Transfection of plasmids using 10% (vol/vol) Neuroporter (Genlantis) was achieved by subretinal injections (1 μL) in mice using a Pico-Injector (PLI-100; Harvard Apparatus).
Drug Injections. Inhibitors of MEK1, p38 MAPK, and JNK were administered by intravitreous injection using a 33-gauge double-caliber needle (Ito Corporation).
In Vitro Transcription of Alu RNA. Alu RNA was synthesized using the AmpliScribe T7-Flash Transcription Kit (Epicentre) according to the manufacturer's instructions.
Transfection and Viral Infection of Cell Culture. Human and mouse RPE cells were pretreated with inhibitors of MEK1, p38 MAPK, and JNK 30 min before transfection. Cells were transfected with plasmids or antisense oligonucleotides using Lipofectamine 2000 according to the manufacturer's instructions. Cells were infected with Ad-Cre-GFP or Ad-Null at multiplicity of infection of 1,000 (Vector Laboratories).
Cell Viability. Cell viability was performed using MTS assays (CellTiter 96 AQueous One Solution Cell Proliferation Assay) according to the manufacturer's instructions (Promega). 
